Becton Dickinson acquires smart medication device maker GSL Solutions
Becton Dickinson (NYSE:BDX) announced today that it acquired smart medication device developer GSL solutions for an […]
Becton Dickinson (NYSE:BDX) announced today that it acquired smart medication device developer GSL solutions for an […]
Vividion Therapeutics has technology that finds ways to hit promising disease targets that were previously […]
Acorda Therapeutics (NSDQ:ACOR) announced today that its chief of business operations, David Lawrence, is resigning from […]
ForDoz Pharma announced today that it entered into an agreement with LipoMedix to manufacture its […]
Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) announced today that they received conditional authorization from European regulators. The […]
Deep Genomics is wasting no time. Two weeks after hiring a new chief business officer […]
Pfizer (NYSE:PFE) and its partner BioNTech (NSDQ:BNTX) announced that they will submit a request today with […]
Vibalogics announced that it initiated the first phase of its planned $150 million investment in a […]
PHILADELPHIA, Oct. 16, 2020 /PRNewswire/ — Enterin, Inc., a privately held, CNS-focused pharmaceutical company based in Philadelphia and developing novel […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.